课题基金 / 基金详情

Regulation of TGF-beta Signaling in the Prostate

Regulation of TGF-beta Signaling in the Prostate
前列腺中 TGF-β 信号传导的调节
批准号:
7048628
负责人:
DAVID DANIELPOUR
金额:
$24.51万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-01 至 2008-03-31

项目摘要

项目成果

DAVID DANIELPOUR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (revised by applicant): In the prostate, transforming growth factor-beta (TGFb) promotes growth arrest and apoptosis of epithelial cells and can either suppress or promotes tumor growth. The mechanisms by which TGFb mediates these processes are under intense investigation. TGFbl signals through promoting the binding and activation of the TGFb type I receptor (TbRI) by TbRII. Activated TbRI phosphorylates Smads 2 and 3, which promotes both their and Smad4's entry in the nucleus, where they directly or indirectly regulate transcription. A current dogma in this field is that TbRII signals only through activation of TbRI. Another dogma is that Smads are the critical trigger of virtually all TGF-b responses including growth arrest and apoptosis. However, accumulating evidence is strengthening the notion that TGFb activates a number of other kinases (i.e., MAPKs) independent of Smads. Despite these advances, nothing is known about how TbRI and TbRII activate such Smad-independent signal. We propose to test the following hypothesis: TbRII is critical to TGFb signal transduction not only through activating TbRI, that activates receptor Smads, but also by mediation of Smad-independent TGFb signals. We will test this hypothesis in prostatic epithelial cell lines by studying: i) the role of EGF in regulating TGFb responses, ii) the structural/functional basis of TbRI and TbRII and the role of Smads and MAPKs in the activation of AP-1, and iii) regulation of growth inhibition by constitutively activated Smads.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of TGF-Beta/Smad Signaling by mTOR in Prostate Cancer
  • 批准号:
    7753389
  • 项目类别:
  • 资助金额:
    $32.58万
  • 财政年份:
    2009
  • 负责人:
    DAVID DANIELPOUR
  • 依托单位:
Control of TGF-Beta/Smad Signaling by mTOR in Prostate Cancer
  • 批准号:
    8234139
  • 项目类别:
  • 资助金额:
    $31.6万
  • 财政年份:
    2009
  • 负责人:
    DAVID DANIELPOUR
  • 依托单位:
Control of TGF-Beta/Smad Signaling by mTOR in Prostate Cancer
  • 批准号:
    8464530
  • 项目类别:
  • 资助金额:
    $29.7万
  • 财政年份:
    2009
  • 负责人:
    DAVID DANIELPOUR
  • 依托单位:
Control of TGF-Beta/Smad Signaling by mTOR in Prostate Cancer
  • 批准号:
    8037807
  • 项目类别:
  • 资助金额:
    $31.6万
  • 财政年份:
    2009
  • 负责人:
    DAVID DANIELPOUR
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: